23 September 2009
Teva and Lundbeck announce New England Journal of Medicine publication of landmark ADAGIO study with Azilect® in Parkinson’s disease
Results of early treatment with AZILECT® 1 mg/day tablets consistent with disease-modifying effect
24th September 2009. Teva and Lundbeck announce that the results of
8 June 2009
EPDA Life with Parkinson’s campaign launches in ten languages to improve knowledge of Parkinson’s disease across Europe
Survey reveals most Europeans know so little about Parkinson’s they would be unlikely to recognise its early symptoms and see their doctor for
